OGN:NYSE
Organon & Co
USD 13,91
arrow_downward
-0,07%(-0,010) 1D
USD 13,61
arrow_downward
-2,16% (-0,30)todayPre-market
Closed: 19 Nov., 16:00:03 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
USD 13,92
High
USD 13,94
Low
USD 13,90
Mkt. cap
3,65 mjd.
Avg. vol.
2,68 m.
Volume
764,00
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,09
52-wk high
USD 13,94
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m.
No. of employees
10 k
Open
USD 13,92
High
USD 13,94
Low
USD 13,90
Mkt. cap
3,65 mjd.
Avg. vol.
2,68 m.
Volume
764,00
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,09
52-wk high
USD 13,94
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m.
No. of employees
10 k
News stories
From web sources and news partners
Seeking Alpha
·
19 uur gelede
Organon: Deal Almost Done, Spread Almost Gone (Sell) (NYSE:OGN)
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 k
Founded1923
HeadquartersJersey City, New Jersey, Verenigde State van Amerika
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com